2018-2023 Global Orphan Diseases Market Report (Status and Outlook)
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Orphan Diseases market for 2018-2023.
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Over the next five years, LPI(LP Information) projects that Orphan Diseases will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Orphan Diseases market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Orphan Diseases market for 2018-2023.
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Over the next five years, LPI(LP Information) projects that Orphan Diseases will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Orphan Diseases market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
- Autoimmune Disorders
- Genetic Disorders
- Cancer
- Growth Disorder
- Cardiovascular Diseases
- Neurological Disorders
- Respiratory Disorders
- Digestive Disorders
- Eye Disorders
- Hospitals And Clinics
- Research Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Novartis
- Celgene
- Roche
- Pfizer
- Alexion
- Sanofi
- Vertex Pharmaceuticals
- GlaxoSmithKline
- Merck
- Abbvie
Research objectives
- To study and analyze the global Orphan Diseases market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Orphan Diseases market by identifying its various subsegments.
- Focuses on the key global Orphan Diseases players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Orphan Diseases with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of Orphan Diseases submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orphan Diseases Market Size 2013-2023
2.1.2 Orphan Diseases Market Size CAGR by Region
2.2 Orphan Diseases Segment by Type
2.2.1 Autoimmune Disorders
2.2.2 Genetic Disorders
2.2.3 Blood Disorders
2.2.4 Cancer
2.2.5 Growth Disorder
2.2.6 Cardiovascular Diseases
2.2.7 Neurological Disorders
2.2.8 Respiratory Disorders
2.2.9 Digestive Disorders
2.2.10 Eye Disorders
2.3 Orphan Diseases Market Size by Type
2.3.1 Global Orphan Diseases Market Size Market Share by Type (2013-2018)
2.3.2 Global Orphan Diseases Market Size Growth Rate by Type (2013-2018)
2.4 Orphan Diseases Segment by Application
2.4.1 Hospitals And Clinics
2.4.2 Research Laboratories
2.5 Orphan Diseases Market Size by Application
2.5.1 Global Orphan Diseases Market Size Market Share by Application (2013-2018)
2.5.2 Global Orphan Diseases Market Size Growth Rate by Application (2013-2018)
3 GLOBAL ORPHAN DISEASES BY PLAYERS
3.1 Global Orphan Diseases Market Size Market Share by Players
3.1.1 Global Orphan Diseases Market Size by Players (2016-2018)
3.1.2 Global Orphan Diseases Market Size Market Share by Players (2016-2018)
3.2 Global Orphan Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ORPHAN DISEASES BY REGIONS
4.1 Orphan Diseases Market Size by Regions
4.2 Americas Orphan Diseases Market Size Growth
4.3 APAC Orphan Diseases Market Size Growth
4.4 Europe Orphan Diseases Market Size Growth
4.5 Middle East & Africa Orphan Diseases Market Size Growth
5 AMERICAS
5.1 Americas Orphan Diseases Market Size by Countries
5.2 Americas Orphan Diseases Market Size by Type
5.3 Americas Orphan Diseases Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Orphan Diseases Market Size by Countries
6.2 APAC Orphan Diseases Market Size by Type
6.3 APAC Orphan Diseases Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Orphan Diseases by Countries
7.2 Europe Orphan Diseases Market Size by Type
7.3 Europe Orphan Diseases Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orphan Diseases by Countries
8.2 Middle East & Africa Orphan Diseases Market Size by Type
8.3 Middle East & Africa Orphan Diseases Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL ORPHAN DISEASES MARKET FORECAST
10.1 Global Orphan Diseases Market Size Forecast (2018-2023)
10.2 Global Orphan Diseases Forecast by Regions
10.2.1 Global Orphan Diseases Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Orphan Diseases Forecast by Type
10.8 Global Orphan Diseases Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Company Details
11.1.2 Orphan Diseases Product Offered
11.1.3 Bristol-Myers Squibb Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Bristol-Myers Squibb News
11.2 Novartis
11.2.1 Company Details
11.2.2 Orphan Diseases Product Offered
11.2.3 Novartis Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Novartis News
11.3 Celgene
11.3.1 Company Details
11.3.2 Orphan Diseases Product Offered
11.3.3 Celgene Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Celgene News
11.4 Roche
11.4.1 Company Details
11.4.2 Orphan Diseases Product Offered
11.4.3 Roche Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Roche News
11.5 Pfizer
11.5.1 Company Details
11.5.2 Orphan Diseases Product Offered
11.5.3 Pfizer Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Pfizer News
11.6 Alexion
11.6.1 Company Details
11.6.2 Orphan Diseases Product Offered
11.6.3 Alexion Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Alexion News
11.7 Sanofi
11.7.1 Company Details
11.7.2 Orphan Diseases Product Offered
11.7.3 Sanofi Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Sanofi News
11.8 Vertex Pharmaceuticals
11.8.1 Company Details
11.8.2 Orphan Diseases Product Offered
11.8.3 Vertex Pharmaceuticals Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Vertex Pharmaceuticals News
11.9 GlaxoSmithKline
11.9.1 Company Details
11.9.2 Orphan Diseases Product Offered
11.9.3 GlaxoSmithKline Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 GlaxoSmithKline News
11.10 Merck
11.10.1 Company Details
11.10.2 Orphan Diseases Product Offered
11.10.3 Merck Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Merck News
11.11 Abbvie
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orphan Diseases Market Size 2013-2023
2.1.2 Orphan Diseases Market Size CAGR by Region
2.2 Orphan Diseases Segment by Type
2.2.1 Autoimmune Disorders
2.2.2 Genetic Disorders
2.2.3 Blood Disorders
2.2.4 Cancer
2.2.5 Growth Disorder
2.2.6 Cardiovascular Diseases
2.2.7 Neurological Disorders
2.2.8 Respiratory Disorders
2.2.9 Digestive Disorders
2.2.10 Eye Disorders
2.3 Orphan Diseases Market Size by Type
2.3.1 Global Orphan Diseases Market Size Market Share by Type (2013-2018)
2.3.2 Global Orphan Diseases Market Size Growth Rate by Type (2013-2018)
2.4 Orphan Diseases Segment by Application
2.4.1 Hospitals And Clinics
2.4.2 Research Laboratories
2.5 Orphan Diseases Market Size by Application
2.5.1 Global Orphan Diseases Market Size Market Share by Application (2013-2018)
2.5.2 Global Orphan Diseases Market Size Growth Rate by Application (2013-2018)
3 GLOBAL ORPHAN DISEASES BY PLAYERS
3.1 Global Orphan Diseases Market Size Market Share by Players
3.1.1 Global Orphan Diseases Market Size by Players (2016-2018)
3.1.2 Global Orphan Diseases Market Size Market Share by Players (2016-2018)
3.2 Global Orphan Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ORPHAN DISEASES BY REGIONS
4.1 Orphan Diseases Market Size by Regions
4.2 Americas Orphan Diseases Market Size Growth
4.3 APAC Orphan Diseases Market Size Growth
4.4 Europe Orphan Diseases Market Size Growth
4.5 Middle East & Africa Orphan Diseases Market Size Growth
5 AMERICAS
5.1 Americas Orphan Diseases Market Size by Countries
5.2 Americas Orphan Diseases Market Size by Type
5.3 Americas Orphan Diseases Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Orphan Diseases Market Size by Countries
6.2 APAC Orphan Diseases Market Size by Type
6.3 APAC Orphan Diseases Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Orphan Diseases by Countries
7.2 Europe Orphan Diseases Market Size by Type
7.3 Europe Orphan Diseases Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orphan Diseases by Countries
8.2 Middle East & Africa Orphan Diseases Market Size by Type
8.3 Middle East & Africa Orphan Diseases Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL ORPHAN DISEASES MARKET FORECAST
10.1 Global Orphan Diseases Market Size Forecast (2018-2023)
10.2 Global Orphan Diseases Forecast by Regions
10.2.1 Global Orphan Diseases Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Orphan Diseases Forecast by Type
10.8 Global Orphan Diseases Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Company Details
11.1.2 Orphan Diseases Product Offered
11.1.3 Bristol-Myers Squibb Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Bristol-Myers Squibb News
11.2 Novartis
11.2.1 Company Details
11.2.2 Orphan Diseases Product Offered
11.2.3 Novartis Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Novartis News
11.3 Celgene
11.3.1 Company Details
11.3.2 Orphan Diseases Product Offered
11.3.3 Celgene Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Celgene News
11.4 Roche
11.4.1 Company Details
11.4.2 Orphan Diseases Product Offered
11.4.3 Roche Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Roche News
11.5 Pfizer
11.5.1 Company Details
11.5.2 Orphan Diseases Product Offered
11.5.3 Pfizer Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Pfizer News
11.6 Alexion
11.6.1 Company Details
11.6.2 Orphan Diseases Product Offered
11.6.3 Alexion Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Alexion News
11.7 Sanofi
11.7.1 Company Details
11.7.2 Orphan Diseases Product Offered
11.7.3 Sanofi Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Sanofi News
11.8 Vertex Pharmaceuticals
11.8.1 Company Details
11.8.2 Orphan Diseases Product Offered
11.8.3 Vertex Pharmaceuticals Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Vertex Pharmaceuticals News
11.9 GlaxoSmithKline
11.9.1 Company Details
11.9.2 Orphan Diseases Product Offered
11.9.3 GlaxoSmithKline Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 GlaxoSmithKline News
11.10 Merck
11.10.1 Company Details
11.10.2 Orphan Diseases Product Offered
11.10.3 Merck Orphan Diseases Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Merck News
11.11 Abbvie
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Table Product Specifications of Orphan Diseases
Figure Orphan Diseases Report Years Considered
Figure Market Research Methodology
Figure Global Orphan Diseases Market Size Growth Rate 2013-2023 (
Table Product Specifications of Orphan Diseases
Figure Orphan Diseases Report Years Considered
Figure Market Research Methodology
Figure Global Orphan Diseases Market Size Growth Rate 2013-2023 (